Evidence map›Paper›PMID 25365643›Full record

ReviewCoronary artery disease2014

Endothelial dysfunction and coronary artery disease: assessment, prognosis, and treatment.

Yasushi Matsuzawa, Amir Lerman

Registry-linked trialOpen access · greenAbstract readReview
In one paragraph

Review in Coronary artery disease, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04046172 (Treatment of Periodontal Disease in Systemic Lupus Erytematosus), which is not on this map. Cited by 110 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
110citing papers in PubMed, 4 pooled it
6.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04046172 naunknown statusnot on this mapstarted 2021, after this paper: background citation

Treatment of Periodontal Disease in Systemic Lupus Erytematosus: A Pilot Randomized Controlled Clinical Trial

TypeinterventionalSponsorUniversity College, LondonRan2021 to 2023Enrolled200ConditionsSystemic Lupus Erythematosus, PeriodontitisArmssupra/sub gingival root surface debridement, supra-gingival scaling and polishing
3 · Its place in the literature

Who cites it

110 citing papers in PubMed, 4 syntheses or guidelines pooled it, 245 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

50 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Yasushi MatsuzawaDepartment of Internal Medicine, Division of Cardiovascular Diseases, Mayo College of Medicine, Rochester, Minnesota, USA.
Amir Lerman
Mayo Clinic · US

Funding

Lp-PLA2 and Coronary Atherosclerosis in HumansR01HL092954 · NHLBI · MAYO CLINIC ROCHESTER · PI LERMAN, AMIR · 2009 to 2013
$2.1M
Role of Endothelial Progenitor Cells in vascular Aging and CalcificationR01AG031750 · NIA · MAYO CLINIC ROCHESTER · PI KHOSLA, SUNDEEP, LERMAN, AMIR · 2010 to 2014
$2.0M
NHLBI NIH HHS HL-92954NHLBI NIH HHS R01 HL092954NIA NIH HHS AG-31750NIA NIH HHS R01 AG031750
6 · The paper itself

Abstract

Progress in the modification of conventional coronary risk factors and lifestyle behavior has reduced the incidence of atherosclerotic coronary artery disease; nonetheless, it continues to be the leading cause of mortality in the world. This might be attributed to the defective risk stratifying and prevention strategy for coronary artery disease. In the current clinical setting, atherosclerotic coronary artery disease risk is estimated on the basis of identifying and quantifying only traditional risk factors; it does not take into consideration nontraditional risk factors. In addition, most of the prevailing therapies for atherosclerosis are targeted toward traditional risk factors rather than atherosclerosis itself. It is desirable to develop a method that can directly assess the activity of atherogenesis at every moment. Endothelial function is an integrated index of all atherogenic and atheroprotective factors present in an individual including nontraditional factors and heretofore unknown factors, and it is reported to have additional predictive value for future cardiovascular events to traditional risk factors. Moreover, endothelial function has a pivotal role in all phases of atherosclerosis, from initiation to atherothrombotic complication, and is reversible at every phase, indicating that endothelial function-guided therapies might be effective and feasible in cardiovascular practice. Thus, the introduction of endothelial function testing into clinical practice might enable us to innovate individualized cardiovascular medicine. In this review, we summarize the current knowledge on the contribution of endothelial dysfunction to atherogenesis and review the methods that assess endothelial function. Finally, we focus on the effects of major antiatherosclerotic disease therapies on endothelial function and argue the possibility of noninvasive assessment of endothelial function aiming at individualized cardiovascular medicine.

Indexed as

Diagnostic Techniques, CardiovascularAnimalsCoronary Artery DiseaseEndothelium, VascularHumansPredictive Value of TestsPrognosisRisk AssessmentRisk Factors

Identifiers

PMID25365643
PMCPMC4220301
OpenAlexW2081776702

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.